share_log

BRIEF-North China Pharmaceutical Says Unit's Anti-Monopoly Case Recinded

reuters ·  Nov 8, 2021 04:46

Nov 8 (Reuters) - North China Pharmaceutical Co LTd

600812.SS :

* SAYS UNIT'S ANTI-MONOPOLY CASE HAS BEEN RECINDED BY U.S. COURT IN NEW YORK

Source text Further company coverage: 600812.SS

(Reporting by Hong Kong newsroom)

((meg.shen@thomsonreuters.com; 852-39525805;))

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment